Aspirin predicts the potential of preventing liver cancer

Share This Post

The researchers found that taking two or more standard doses (325 mg) of pills per week reduced the risk of liver cancer by 49%. Compared with people who do not often use aspirin or do not use aspirin, the frequent use of aspirin causes a significantly lower risk of liver cancer. With the extension of aspirin dose and duration of use, the risk of liver cancer gradually decreased. However, it should be noted that this study does not prove that aspirin can reduce the risk caused by the liver, but there is a correlation.

In this study, the researchers analyzed long-term data for more than 45 800 women and 87 500 men in the United States. The researchers report that the protective effect of aspirin increases over time. In patients taking aspirin for 5 years or more, the risk of liver cancer was reduced by 59%. Studies have shown that regular use of non-steroidal anti-inflammatory drugs such as acetaminophen (Tylenol) or febuprofen (Motrin, Advil) is not related to reducing the risk of liver cancer. The results were published in “JAMA Oncology”.

However, routine use of aspirin increases the risk of bleeding, and the next step should be to study its effect on patients with confirmed liver disease. Senior study author Dr. Andrew Chan noted that “aspirin has been recommended for use by some American adults to prevent heart disease and colorectal cancer.”

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

How Targeted Therapy is Revolutionizing Advanced Cancer Treatment

How Targeted Therapy is Revolutionizing Advanced Cancer Treatment?

In the field of oncology, the emergence of targeted therapy has revolutionized the treatment landscape for advanced cancers. Unlike conventional chemotherapy, which broadly targets rapidly dividing cells, targeted therapy aims to selectively attack cancer cells while minimizing damage to normal cells. This precision approach is made possible by identifying specific molecular alterations or biomarkers that are unique to cancer cells. By understanding the molecular profiles of tumors, oncologists can tailor treatment regimens that are more effective and less toxic. In this article, we delve into the principles, applications, and advancements of targeted therapy in advanced cancer.

Utilizing Immunotherapy to Treat Late-Stage Cancers

Utilizing Immunotherapy to Treat Late-Stage Cancers

  Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard medicines. This

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy